VEGFA and glioblastoma: Nevertheless, anti-VEGF agents are reported to decrease the risk of glioblastoma-associated brain edema in both mice and patients (162, 163), offering promise for the combination of anti-VEGF therapy and ICIs in the treatment of glioblastoma and possibly brain metastases.